Services · IndoyangAI

IndoyangAI, your Korea–India desk

Sign in and IndoyangAI keeps you up to date on Korea and India every day: industry news in four languages, market reports, regulatory changes explained in plain words, and an assistant that answers your questions about all of it.

The latest from Korea and India

News about “Bio & pharma”

9 stories found · Ask IndoyangAI about this

Korea–India industry digest · Free · members-only section

Bio & pharma: Indoyang Connect industry digest cover

Korea counts 45 home-grown new drugs as it seeks faster development

Korea's health ministry convened industry and government on November 18 to review domestic new drug development, noting 45 approved home-grown drugs and a 6% global share of drug candidates. The drug safety regulator also marked the 40th Pharmacy Day and issued two medical device guidelines.

Korea–India industry digest · Free · members-only section

Bio & pharma: Indoyang Connect industry digest cover

Korea's drug regulator steers bio and pharma toward AI and digital medicine

Over the past three weeks, Korea's Ministry of Food and Drug Safety has put AI, digital medical devices and digital convergence medicines at the centre of its agenda. Alongside, Seoul has eased medicine access, tightened online enforcement and raised its international regulatory profile.

Korea–India industry digest · Free · members-only section

Bio & pharma: Indoyang Connect industry digest cover

Korea's drug regulator steps up push on digital convergence medicines

Korea's Ministry of Food and Drug Safety held two days of industry consultations on digital convergence medicines and digital medical devices, alongside events on AI-based quality control and innovative devices. It also reported 571 online illegal drug sales and brokering cases ahead of the college entrance exam.

Korea–India industry digest · Free · members-only section

Bio & pharma: Indoyang Connect industry digest cover

Korea's drug regulator widens global reach as domestic rules tighten

Korea's Ministry of Food and Drug Safety spent early November raising its international profile and tightening oversight at home, while the government pushes to grow 200 frontier pharma-bio companies.

Korea–India industry digest · Free · members-only section

Bio & pharma: Indoyang Connect industry digest cover

Korea's drug regulators widen access and push for global standing

Korea's pharma and device regulators spent the past three weeks expanding medicine access, adding safety measures and building international ties. Seoul is also backing industrial plans for AI-driven bio and 200 frontier firms.

Korea–India industry digest · Free · members-only section

Bio & pharma: Indoyang Connect industry digest cover

Korea's drug regulators push global standing and wider medicine access

Korea's health and drug authorities spent the past three weeks widening access to medicines, tightening safety oversight and raising their international profile. Industry policy is building alongside, with plans for 200 pharma-bio frontier firms and a sovereign AI-bio strategy.

Korea–India industry digest · Free · members-only section

Bio & pharma: Indoyang Connect industry digest cover

Korea moves to let military bases and airports stock common medicines

Korea's health ministry has proposed rules to bring household medicines to military units, small regional airports and island ferries without nearby pharmacies. Drug regulators also announced steps on GLP-1 drug safety, PIC/S assessment work and fee reform.

Clear the search

Inside the platform

One platform to connect the world

Sign in and Indoyang Connect works alongside you every day, from the first question to the first shipment.

  • Get updated about India
  • Talk to your Indian specialist
  • Learn the market
  • Study the gap
  • Read the daily industry digest
  • Find the right partner
  • Scout factory and office sites
  • Open full Pro reports
  • Ask IndoyangAI anything
  • Track Korea–India trade
The Indoyang Connect mascot: a round little tiger cub with big floppy ears

Start free, upgrade when you need more

A free account opens the news and members-only sections.

Pro opens every report and IndoyangAI; Max adds updates on your schedule.

See membership prices